| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A systematic review of transfusion-associated graft-versus-host disease
|
Kopolovic, Ilana
|
|
|
126 |
3 |
p. 406-414
|
artikel
|
| 2 |
Azacitidine in AML: a treatment option?
|
Huls, Gerwin
|
|
|
126 |
3 |
p. 283-284
|
artikel
|
| 3 |
Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis
|
Iyer, Neel S.
|
|
|
126 |
3 |
p. 346-353
|
artikel
|
| 4 |
da Silva MCF, Zuccherato LW, Lucena FC, et al. Extensive admixture in Brazilian sickle cell patients: implications for the mapping of genetic modifiers. Blood. 2011;118(16):4493-4495.
|
|
|
|
126 |
3 |
p. 425b
|
artikel
|
| 5 |
Dengue virus binding and replication by platelets
|
Simon, Ayo Y.
|
|
|
126 |
3 |
p. 378-385
|
artikel
|
| 6 |
Dengue virus pirates human platelets
|
Rondina, Matthew T.
|
|
|
126 |
3 |
p. 286-287
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
126 |
3 |
p. i
|
artikel
|
| 8 |
Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy
|
Arai, Yasuyuki
|
|
|
126 |
3 |
p. 415-422
|
artikel
|
| 9 |
Frishman-Levy L, Shemesh A, Bar-Sinai A, et al. Central nervous system acute lymphoblastic leukemia: role of natural killer cells. Blood. 2015;125(22):3420-3431.
|
|
|
|
126 |
3 |
p. 425
|
artikel
|
| 10 |
How I treat refractory and early relapsed acute myeloid leukemia
|
Thol, Felicitas
|
|
|
126 |
3 |
p. 319-327
|
artikel
|
| 11 |
Inhibition of Mcl-1 with the pan–Bcl-2 family inhibitor (–)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia
|
Pan, Rongqing
|
|
|
126 |
3 |
p. 363-372
|
artikel
|
| 12 |
Interaction of kindlin-3 and β2-integrins differentially regulates neutrophil recruitment and NET release in mice
|
Xu, Zhen
|
|
|
126 |
3 |
p. 373-377
|
artikel
|
| 13 |
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|
Dombret, Hervé
|
|
|
126 |
3 |
p. 291-299
|
artikel
|
| 14 |
mTOR inhibition in T-cell lymphoma: a path(way) forward
|
Moskowitz, Alison J.
|
|
|
126 |
3 |
p. 284-286
|
artikel
|
| 15 |
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma
|
Jain, Salvia
|
|
|
126 |
3 |
p. 354-362
|
artikel
|
| 16 |
Pericardial involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma
|
Danilova, Olga V.
|
|
|
126 |
3 |
p. 424
|
artikel
|
| 17 |
Promising therapies in multiple myeloma
|
Bianchi, Giada
|
|
|
126 |
3 |
p. 300-310
|
artikel
|
| 18 |
Rare and strange invader
|
Kadi, Wendy
|
|
|
126 |
3 |
p. 423
|
artikel
|
| 19 |
Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency
|
Pike, Gillian N.
|
|
|
126 |
3 |
p. 397-405
|
artikel
|
| 20 |
Schinke C, Giricz O, Li W, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125(20):3144-3152.
|
|
|
|
126 |
3 |
p. 425a
|
artikel
|
| 21 |
STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma
|
Wu, Chengsheng
|
|
|
126 |
3 |
p. 336-345
|
artikel
|
| 22 |
Systematic review of TA-GVHD
|
|
|
|
126 |
3 |
p. 426
|
artikel
|
| 23 |
The human microbiome in hematopoiesis and hematologic disorders
|
Manzo, Veronica E.
|
|
|
126 |
3 |
p. 311-318
|
artikel
|
| 24 |
The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice
|
Cui, Shuaiying
|
|
|
126 |
3 |
p. 386-396
|
artikel
|
| 25 |
The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma
|
Witzig, Thomas E.
|
|
|
126 |
3 |
p. 328-335
|
artikel
|
| 26 |
Thrombin generation: biochemical possibilities and clinical reality
|
Hemker, H. Coenraad
|
|
|
126 |
3 |
p. 288-289
|
artikel
|
Tijdschrift beschrijving